RK-682 is an inhibitor of protein tyrosine phosphatase (PTPase), heparanase, phospholipase A2, and HIV-1 protease; it inhibits CD45 and VHR dephosphorylation (IC50 = 54 μM for both), thereby suppressing the ERK signaling pathway; it reduces cell viability in cancer cell lines MGH-U3, T24, and UROtsa (IC50 = 78.2, 43.2, and 145 nM, respectively); it induces G1/S cell cycle arrest and inhibits cell migration and autophagy in MGH-U3 and T24 cells.